ReMeDy: a platform for integrating and sharing published stem cell research data with a focus on iPSC trials

Abstract Abstract Recent regenerative medicine studies have emphasized the need for increased standardization, harmonization and sharing of information related to stem cell product characterization, to help drive these innovative interventions toward public availability and to increase collaboration in the scientific community. Although numerous attempts and numerous databases have been made to manage these data, a platform that incorporates all the heterogeneous data collected from stem cell projects into a harmonized project-based framework is still lacking. The aim of the database, which is described in this study, is to provide an intelligent informatics solution that integrates comprehensive characterization of diverse stem cell product characteristics with research subject and project outcome information. In the resulting platform, heterogeneous data are validated using predefined ontologies and stored in a relational database, to ensure data quality and ease of access. Testing was performed using 51 published, publically available induced pluripotent stem cell projects conducted in clinical, preclinical and in-vitro evaluations. Future aims of this project include further increasing the database size to include all published stem cell trials and develop additional data visualization tools to improve usability. Our testing demonstrated the robustness of the proposed platform, by seamlessly harmonizing diverse common data elements, and the potential of this platform for driving knowledge generation from the aggregation and harmonization of these diverse data. Database URL https://remedy.mssm.edu/

[1]  D. Broering,et al.  iPSC-derived MSC therapy induces immune tolerance and supports long-term graft survival in mouse orthotopic tracheal transplants , 2019, Stem Cell Research & Therapy.

[2]  J. Dutton,et al.  Generation of retinal pigmented epithelium from iPSCs derived from the conjunctiva of donors with and without age related macular degeneration , 2017, PloS one.

[3]  M. Tzetis,et al.  Therapeutic Effects of Mesenchymal Stem Cells Derived From Bone Marrow, Umbilical Cord Blood, and Pluripotent Stem Cells in a Mouse Model of Chemically Induced Inflammatory Bowel Disease , 2019, Inflammation.

[4]  M. Kondo,et al.  Preparation of Induced Pluripotent Stem Cells Using Human Peripheral Blood Monocytes , 2018, Cellular reprogramming.

[5]  Jiaqian Wu,et al.  Human neural progenitors derived from integration-free iPSCs for SCI therapy , 2017, Stem cell research.

[6]  Y. Sekino,et al.  Specific induction and long-term maintenance of high purity ventricular cardiomyocytes from human induced pluripotent stem cells , 2020, PloS one.

[7]  A. Akabayashi,et al.  The world’s first clinical trial for an aplastic anemia patient with thrombocytopenia administering platelets generated from autologous iPS cells , 2018, International Journal of Hematology.

[8]  H. Miyoshi,et al.  Enhancing T Cell Receptor Stability in Rejuvenated iPSC-Derived T Cells Improves Their Use in Cancer Immunotherapy. , 2018, Cell stem cell.

[9]  S. Kang,et al.  Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans. , 2011, Stem cells and development.

[10]  Nathan Hotaling,et al.  Clinical-grade stem cell–derived retinal pigment epithelium patch rescues retinal degeneration in rodents and pigs , 2019, Science Translational Medicine.

[11]  Julie A. Johnson,et al.  Vascular Smooth Muscle Cells From Hypertensive Patient‐Derived Induced Pluripotent Stem Cells to Advance Hypertension Pharmacogenomics , 2015, Stem cells translational medicine.

[12]  L. Minter,et al.  Cymerus™ iPSC-MSCs significantly prolong survival in a pre-clinical, humanized mouse model of Graft-vs-host disease , 2019, Stem cell research.

[13]  Amit N. Patel,et al.  Surgical treatment for congestive heart failure with autologous adult stem cell transplantation: a prospective randomized study. , 2005, The Journal of thoracic and cardiovascular surgery.

[14]  T. Watabe,et al.  Transplantation of Human-induced Pluripotent Stem Cell-derived Cardiomyocytes Is Superior to Somatic Stem Cell Therapy for Restoring Cardiac Function and Oxygen Consumption in a Porcine Model of Myocardial Infarction , 2019, Transplantation.

[15]  Yutaka Suzuki,et al.  Long-term expansion of alveolar stem cells derived from human iPS cells in organoids , 2017, Nature Methods.

[16]  V. Silani,et al.  Motor neuron differentiation of iPSCs obtained from peripheral blood of a mutant TARDBP ALS patient. , 2018, Stem cell research.

[17]  K. Deisseroth,et al.  Activity in grafted human iPS cell–derived cortical neurons integrated in stroke-injured rat brain regulates motor behavior , 2020, Proceedings of the National Academy of Sciences.

[18]  A. Simeone,et al.  Establishment of stable iPS-derived human neural stem cell lines suitable for cell therapies , 2018, Cell Death & Disease.

[19]  Takashi Daimon,et al.  Autologous Induced Stem‐Cell–Derived Retinal Cells for Macular Degeneration: Brief Report , 2017, The New England journal of medicine.

[20]  M. Acker,et al.  Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure: A Randomized Clinical Trial , 2019, Journal of the American Medical Association (JAMA).

[21]  Y. Tabata,et al.  Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes. , 2019, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[22]  E. Andreu,et al.  Randomized Placebo-Controlled Phase II Trial of Autologous Mesenchymal Stem Cells in Multiple Sclerosis , 2014, PloS one.

[23]  Ying Ge,et al.  Cardiac repair in a porcine model of acute myocardial infarction with human induced pluripotent stem cell-derived cardiovascular cells. , 2014, Cell stem cell.

[24]  W. Shi,et al.  Rapid Differentiation of Multi-Zone Ocular Cells from Human Induced Pluripotent Stem Cells and Generation of Corneal Epithelial and Endothelial Cells. , 2019, Stem cells and development.

[25]  D. Kaufman,et al.  Clinical‐Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy , 2013, Stem cells translational medicine.

[26]  Y. Mao,et al.  Tracking induced pluripotent stem cells-derived neural stem cells in the central nervous system of rats and monkeys. , 2013, Cellular reprogramming.

[27]  Emanuela Monni,et al.  Human‐Induced Pluripotent Stem Cells form Functional Neurons and Improve Recovery After Grafting in Stroke‐Damaged Brain , 2012, Stem cells.

[28]  J. Rasko,et al.  Production, safety and efficacy of iPSC-derived mesenchymal stromal cells in acute steroid-resistant graft versus host disease: a phase I, multicenter, open-label, dose-escalation study , 2020, Nature medicine.

[29]  S. Salani,et al.  Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model , 2013, Human molecular genetics.

[30]  I. Endo,et al.  Type I Interferon Delivery by iPSC-Derived Myeloid Cells Elicits Antitumor Immunity via XCR1+ Dendritic Cells. , 2019, Cell reports.

[31]  N. Bresolin,et al.  CSF transplantation of a specific iPSC-derived neural stem cell subpopulation ameliorates the disease phenotype in a mouse model of spinal muscular atrophy with respiratory distress type 1 , 2019, Experimental Neurology.

[32]  L. Niklason,et al.  Xenogeneic-free Generation of Vascular Smooth Muscle Cells from Human Induced Pluripotent Stem Cells for Vascular Tissue Engineering. , 2020, Acta biomaterialia.

[33]  S. Malik,et al.  Autologous mesenchymal stromal cell transplantation for spinal cord injury: A Phase I pilot study. , 2016, Cytotherapy.

[34]  C. Mayhew,et al.  Intravenous infusion of iPSC-derived neural precursor cells increases acid β-glucosidase function in the brain and lessens the neuronopathic phenotype in a mouse model of Gaucher disease. , 2019, Human molecular genetics.

[35]  S. Ogawa,et al.  KLF1 mutation E325K induces cell cycle arrest in erythroid cells differentiated from congenital dyserythropoietic anemia patient-specific induced pluripotent stem cells. , 2019, Experimental hematology.

[36]  K. Qian,et al.  Modeling hallmark pathology using motor neurons derived from the family and sporadic amyotrophic lateral sclerosis patient-specific iPS cells , 2018, Stem Cell Research & Therapy.

[37]  S. Tsang,et al.  3 1 2 | L I E T a L . | M O L M E D 1 8 : 1 3 1 2 -1 3 1 9 , 2 0 1 2 , 2022 .

[38]  Ravi Iyengar,et al.  The Library of Integrated Network-Based Cellular Signatures NIH Program: System-Level Cataloging of Human Cells Response to Perturbations. , 2017, Cell systems.

[39]  X. Navarro,et al.  Effects of the Post-Spinal Cord Injury Microenvironment on the Differentiation Capacity of Human Neural Stem Cells Derived from Induced Pluripotent Stem Cells , 2016, Cell transplantation.

[40]  L. Arseniev,et al.  GMP-compatible manufacturing of three iPS cell lines from human peripheral blood. , 2019, Stem Cell Research.

[41]  Yo Tanaka,et al.  Establishment of a heart-on-a-chip microdevice based on human iPS cells for the evaluation of human heart tissue function , 2020, Scientific Reports.

[42]  Adan Chari Jirmo,et al.  Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis , 2014, Science Translational Medicine.

[43]  D. Gutmann,et al.  Humanized neurofibroma model from induced pluripotent stem cells delineates tumor pathogenesis and developmental origins. , 2020, The Journal of clinical investigation.

[44]  Alex Gutteridge,et al.  Pharmacological reversal of a pain phenotype in iPSC-derived sensory neurons and patients with inherited erythromelalgia , 2016, Science Translational Medicine.

[45]  S. Senju,et al.  Induced pluripotent stem cell-derived myeloid cells expressing OX40 ligand amplify antigen-specific T cells in advanced melanoma. , 2020, Pigment cell & melanoma research.

[46]  W. Fujibuchi,et al.  First Proposal of Minimum Information About a Cellular Assay for Regenerative Medicine , 2016, Stem cells translational medicine.

[47]  L. Guarente,et al.  Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c–SIRT2 axis , 2017, Nature Cell Biology.

[48]  Tetsuhiro Kikuchi,et al.  Pre-clinical study of induced pluripotent stem cell-derived dopaminergic progenitor cells for Parkinson’s disease , 2020, Nature Communications.

[49]  M. Yamato,et al.  Generation of Corneal Epithelial Cells from Induced Pluripotent Stem Cells Derived from Human Dermal Fibroblast and Corneal Limbal Epithelium , 2012, PloS one.

[50]  S. Miyagawa,et al.  Syngeneic Mesenchymal Stem Cells Reduce Immune Rejection After Induced Pluripotent Stem Cell-Derived Allogeneic Cardiomyocyte Transplantation , 2020, Scientific Reports.

[51]  Ping Zhang,et al.  Patient-Specific and Gene-Corrected Induced Pluripotent Stem Cell-Derived Cardiomyocytes Elucidate Single-Cell Phenotype of Short QT Syndrome , 2019, Circulation research.

[52]  Joseph Finkelstein,et al.  Informatics Approaches for Harmonized Intelligent Integration of Stem Cell Research , 2020, Stem cells and cloning : advances and applications.

[53]  Avi Ma'ayan,et al.  Towards Intelligent Integration and Sharing of Stem Cell Research Data. , 2020, Studies in health technology and informatics.